Anti-CD38 monoclonal antibody-saporin conjugate

Drug Profile

Anti-CD38 monoclonal antibody-saporin conjugate

Alternative Names: Monoclonal antibody OKT10-saporin conjugate; OKT10-saporin conjugate

Latest Information Update: 05 Oct 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Immunotoxins; Monoclonal antibodies
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Acute lymphoblastic leukaemia; Lymphoma

Most Recent Events

  • 05 Oct 2001 No-Development-Reported for Acute lymphoblastic leukaemia in United Kingdom (Unknown route)
  • 05 Oct 2001 No-Development-Reported for Lymphoma in United Kingdom (Unknown route)
  • 02 Oct 2001 A preclinical study has been added to the Cancer pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top